Importance of Candida species other than C. albicans as pathogens in oncology patients.
about
Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicansFungicidal activity of fluconazole against Candida albicans in a synthetic vagina-simulative mediumPerformance of CHROMAGAR candida and BIGGY agar for identification of yeast speciesRisk factors for fatal candidemia caused by Candida albicans and non-albicans Candida speciesAntifungal resistance in pathogenic fungiCandida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005Characterization of agglutinin-like sequence genes from non-albicans Candida and phylogenetic analysis of the ALS familyDouble-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patientsA new tool to quantify receptor recruitment to cell contact sites during host-pathogen interactionNational surveillance of fungemia in Denmark (2004 to 2009)Sensitivity of clinical isolates of Candida to essential oils from Burseraceae familyEpidemiology of invasive candidiasis: a persistent public health problemInternational surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY ParBloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.Candida pseudorugosa sp. nov., a novel yeast species from sputum.Rapid identification of Candida species with species-specific DNA probesCandida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.Fungal PDR transporters: Phylogeny, topology, motifs and function.Candida dubliniensis: characteristics and identification.Panfungal PCR assay for detection of fungal infection in human blood specimens.Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR.Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003.Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.Potential role of phospholipases in virulence and fungal pathogenesis.Fungal infections in transplant and oncology patients.Rapid identification of up to three Candida species in a single reaction tube by a 5' exonuclease assay using fluorescent DNA probes.Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital.Comparison of the API Candida system with the AUXACOLOR system for identification of common yeast pathogens.Reverse cross blot hybridization assay for rapid detection of PCR-amplified DNA from candida species, Cryptococcus neoformans, and Saccharomyces cerevisiae in clinical samples.Identification and phylogenetic relationship of the most common pathogenic Candida species inferred from mitochondrial cytochrome b gene sequencesOutbreak of Pichia anomala infection in the pediatric service of a tertiary-care center in Northern India.Depletion of the squalene synthase (ERG9) gene does not impair growth of Candida glabrata in mice.Prospective study of Candida species in patients at a comprehensive cancer centerCandida albicans and Candida krusei differentially induce human blood mononuclear cell interleukin-12 and gamma interferon production.Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.Susceptibility of clinical isolates of Candida to photodynamic effects of curcumin.Calcineurin controls hyphal growth, virulence, and drug tolerance of Candida tropicalis.Emerging Issues in Nosocomial Fungal Infections.Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study.Therapy for fungal infections in leukemia.
P2860
Q24550731-97555B8D-2BE8-4D69-89B0-A7DCA38FBA7BQ24630977-25EBBF71-2E23-4510-A709-DB0EDEB7E5FCQ24797201-4C79FBB0-DD4B-4893-B484-0920C1736608Q24799296-49097CF2-2C97-437A-851F-4920CA2EDA2DQ28208165-93BB83A4-6A75-488A-A1D2-12E81BE977FFQ28260910-07ABB14A-37C3-446E-8137-A9DE9A46361EQ28362099-6F9E7391-F530-44EA-BC9A-F2F1E41DBEB2Q28362691-B8465879-66F6-4FCE-8AFA-D9F9C4C5EE02Q28539165-ED808BAE-3702-47E8-B2E3-74439E301BD8Q28743556-D5BFC64C-4639-480A-961E-91A46BA44AF8Q28830247-CBCF18E0-E02E-4721-8690-89A0D8E9FA64Q29616758-47EDD468-F571-47AA-9145-1E09EA2C5470Q30453440-CD07F1DD-F0AE-4411-B0AE-C1E768A9D9EBQ30453663-8E1F35E6-FB5C-4C0D-8026-C33A9D5E3FFAQ31064491-0814D425-F5EE-42BA-B34E-60BB9DEFAB13Q31998547-2F426619-E3B7-4168-AAFF-A0158D379A9CQ33340528-C3A0A9AF-79B1-40E9-BF13-5CBFEDD6CDA9Q33624643-01403E45-C9B4-45B7-8619-1D8B510963ECQ33655501-0C692107-6900-4B4A-8FE6-AFBCD2530B65Q33665050-214769F1-C21E-4DF2-A02A-879A77B2EA4EQ33699122-EF0265C9-1032-4D80-9525-DB4C85FADB25Q33753405-A729614B-B64A-479E-94B4-87FF231936C3Q33805788-A69F2A26-F1AF-436B-AEF2-C9D0B07F5C38Q33812431-C152B311-BBF8-4A4B-889D-7DCFEAF1A498Q33896940-86986166-F637-4C4D-9757-5F368FF38D08Q33958156-9E33E64F-AF0C-4355-BF94-8CAC0EE405D5Q33959121-B839CA6D-55F7-4B92-8754-D1CA8B99E640Q33959438-C2E18C74-1D29-47A7-B48B-87B35311AB2BQ33966544-99953BF6-CD5B-4680-AE8E-2324194C471FQ33970604-1FDFDB47-985F-4BD1-9E21-CF868428D6D3Q33972156-9E51E999-F839-4E77-8EC9-D90653F87E77Q33980488-AE60C0AC-A74B-4869-BEF9-70C72AB84CE9Q33982572-313ABF4E-00B8-4E9A-A4C4-1D55D5E77B9AQ34004133-172E6F7D-7B5A-4D46-9051-D48C7AEE36FBQ34008664-EB30B80B-379D-4A8B-9A72-B1363764DB64Q34050312-5F064DB9-7B18-47BC-8409-44E08AE4BEAEQ34057053-E9AFCFEB-D787-4FE1-880C-BFE57902193BQ34092228-62DFCB11-B20B-45A5-958E-6D56216641FDQ34123634-B845330A-E687-4E88-B424-4D8E78A45974Q34214827-FE812988-7D10-4E4C-BAC9-A20AB59EC4AB
P2860
Importance of Candida species other than C. albicans as pathogens in oncology patients.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Importance of Candida species other than C. albicans as pathogens in oncology patients.
@en
type
label
Importance of Candida species other than C. albicans as pathogens in oncology patients.
@en
prefLabel
Importance of Candida species other than C. albicans as pathogens in oncology patients.
@en
P356
P1476
Importance of Candida species other than C. albicans as pathogens in oncology patients.
@en
P2093
Wingard JR
P304
P356
10.1093/CLINIDS/20.1.115
P407
P577
1995-01-01T00:00:00Z